Madrigal Pharmaceuticals

NCT01367873

Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects

NCT01519531

Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects

NCT02542969

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

NCT02749578

Drug Interaction Study of MGL-3196 With Atorvastatin

NCT03220165

Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196

NCT03413124

Bioavailability Study of MGL-3196 Tablets Compared to Capsules

NCT04643795

Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects

NCT04671056

Drug Interaction Study of MGL-3196 With Pioglitazone

NCT04671069

Drug Interaction Study of MGL-3196 With Clopidogrel

NCT06397872

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function